MedSource
Ergomed Clinical Research is a global Contract Research Organization (CRO) with over 25 years of experience, specializing in oncology, rare disease, and complex clinical trials. They provide tailored, high-quality clinical research solutions, leveraging deep scientific expertise and a strong U.S. presence to accelerate drug development and improve patient outcomes.
Industries
Nr. of Employees
medium (51-250)
MedSource
Houston, Texas, United States, North America
Products
Ergomed CARE™
A proprietary clinical trial support system designed to improve patient enrollment, engagement, and retention by supporting patients, investigators, and clinical sites throughout the trial.
Ergomed CRO Management Services - Project Management Experts
Comprehensive Clinical Research Organization (CRO) management services specializing in clinical trial project management with expertise in oncology, rare diseases, and complex studies.
nowEDC
nowEDC is an electronic data capture (EDC) platform selected by MedSource as their e-clinical software solution of choice, providing real-time data access, dynamic reporting, and compliance with regulatory standards.
Staff Augmentation
A staffing support model providing flexible resource augmentation for clinical, technical, and executive professionals in Life Science organizations.
Direct Placements
A staffing support model providing direct placement of clinical, technical, and executive professionals in Life Science organizations.
Functional Service Provider (FSP)
A staffing support model offering specialized functional service provider solutions for clinical and executive roles in Life Science organizations.
Ergomed CARE™
A proprietary clinical trial support system designed to improve patient enrollment, engagement, and retention by supporting patients, investigators, and clinical sites throughout the trial.
Ergomed CRO Management Services - Project Management Experts
Comprehensive Clinical Research Organization (CRO) management services specializing in clinical trial project management with expertise in oncology, rare diseases, and complex studies.
nowEDC
nowEDC is an electronic data capture (EDC) platform selected by MedSource as their e-clinical software solution of choice, providing real-time data access, dynamic reporting, and compliance with regulatory standards.
Staff Augmentation
A staffing support model providing flexible resource augmentation for clinical, technical, and executive professionals in Life Science organizations.
Direct Placements
A staffing support model providing direct placement of clinical, technical, and executive professionals in Life Science organizations.
Functional Service Provider (FSP)
A staffing support model offering specialized functional service provider solutions for clinical and executive roles in Life Science organizations.
Services
Strategic regulatory and clinical development advisory spanning early planning, trial design, regulatory guidance and post-launch evidence generation.
Site feasibility, selection, contract and budget negotiation, and study activation support to accelerate go-live timelines.
Dedicated site managers and study physician services to support investigator engagement, local training, recruitment strategy and clinical implementation.
Patient-centric operational services including education, logistics support, travel and reimbursement facilitation, home nursing coordination, and retention interventions.
Monitoring services that utilize targeted source data verification and risk-based oversight to ensure data quality and protocol compliance.
Comprehensive biometrics services including clinical data management, statistical planning, programming and regulatory-ready analyses.
Strategic regulatory and clinical development advisory spanning early planning, trial design, regulatory guidance and post-launch evidence generation.
Site feasibility, selection, contract and budget negotiation, and study activation support to accelerate go-live timelines.
Dedicated site managers and study physician services to support investigator engagement, local training, recruitment strategy and clinical implementation.
Patient-centric operational services including education, logistics support, travel and reimbursement facilitation, home nursing coordination, and retention interventions.
Monitoring services that utilize targeted source data verification and risk-based oversight to ensure data quality and protocol compliance.
Comprehensive biometrics services including clinical data management, statistical planning, programming and regulatory-ready analyses.
Expertise Areas
- Clinical trial management
- Early-phase and first-in-human trials
- Oncology clinical development
- Rare disease development
Key Technologies
- Clinical Trial Management Systems (CTMS)
- Electronic Trial Master File (eTMF)
- Electronic data capture and clinical data management
- Statistical analysis and programming (SAS/R)
News & Updates
A case study highlighting Ergomed’s support in a Phase II Gynecologic Oncology trial, focusing on patient enrollment and country-specific approval delays.
A case study on Ergomed’s approach to Phase II Oncology and Viral Hepatitis trials, emphasizing site selection and investigator engagement.
A webinar series in Cambridge, UK, on strategies for drug development including rare diseases.
Insights into the evolution of oncology drug development and Ergomed’s site support model.
An article on ADCs and their role in breast cancer treatment.
An article on the complexities of first-in-human oncology trials and strategies for success.
A case study highlighting Ergomed’s support in a Phase II Gynecologic Oncology trial, focusing on patient enrollment and country-specific approval delays.
A case study on Ergomed’s approach to Phase II Oncology and Viral Hepatitis trials, emphasizing site selection and investigator engagement.
A webinar series in Cambridge, UK, on strategies for drug development including rare diseases.
Insights into the evolution of oncology drug development and Ergomed’s site support model.
An article on ADCs and their role in breast cancer treatment.
An article on the complexities of first-in-human oncology trials and strategies for success.